Zealand Pharma — Marts 2023
-
Morning stars
-
tester 250.....
-
synes returen fra @250 er under lav volume og mere biotek generelt. I går kraftig stigning under lav omsætning - når det er denne "model" er jeg rolig
-
skulle stå HØJ omsætning i går - sorry
-
Så kommer der lige en rettet emission
-
-
Rettidigt omhu. Zealand Pharma vil komme til at stå stærkere i partnerforhandlingerne.
-
"Zealand expects the new funds to provide cash runway to mid-2026 and expects to advance the clinical pipeline and as such reach several potential key milestones within this time frame.
-
The Company is prioritizing resources on R&D and expects to engage in strategic partnerships for commercialization and co-development",
-
Zealand Pharma laver rettet emission på 6,5 mio. nye aktier https://www.proinvestor.com/investornyt/961900/zealand-pharma-laver-rettet-emission-pa-65-mio-nye-aktier
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind